Chemical formula: C₂₆H₃₅F₃O₆ Molecular mass: 500.548 g/mol PubChem compound: 5282226
Travoprost, a prostaglandin F2α analogue, is a highly selective full agonist which has a high affinity for the prostaglandin FP receptor, and reduces the intraocular pressure by increasing the outflow of aqueous humour via trabecular meshwork and uveoscleral pathways.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01EE04 | Travoprost | S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| TRAVATAN Eye drops, solution | European Medicines Agency (EU) | MPI, EU: SmPC |
Travoprost is an active ingredient of these brands:
United States (US)Albania (AL)
Austria (AT)Brazil (BR)
Canada (CA)
Cyprus (CY)
Ecuador (EC)Estonia (EE)Germany (DE)
Lithuania (LT)Mexico (MX)Nigeria (NG)
Poland (PL)Romania (RO)
Singapore (SG)
Spain (ES)
Turkey (TR)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
